CEL-SCI (CVM) Stock Price
CEL-SCI Price
Over the last 14 years CEL-SCI grew revenue by 11.3% annually, reaching 558,664.00 USD. For CEL-SCI, the net margin of -5,419.5% is down versus -4,022.6% a few years ago. The consensus 12-month price target for CEL-SCI is 6.32 USD, about 278.7% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus. The stock trades about 71% above its 52-week low.
CEL-SCI stock price
CEL-SCI business model & stock analysis
Frequently asked questions about CEL-SCI
5 analysts currently rate the CEL-SCI stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the CEL-SCI share trades at 1.47 EUR (1.67 USD).
The CEL-SCI share (CVM) is listed on 4 stock exchanges, including: Frankfurt (LSRM.F), München (LSRM.MU), Düsseldorf (LSRM.DU).
No history available for CEL-SCI.
The revenue cannot currently be calculated for CEL-SCI.
The expected profit of CEL-SCI is -4.55 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of CEL-SCI is currently -2.94. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the CEL-SCI stock.
The P/S cannot be calculated for CEL-SCI currently.
The Eulerpool Quality Score for CEL-SCI is 2/10.
The ISIN of CEL-SCI is US1508377066. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of CEL-SCI is A2DY0D. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of CEL-SCI is CVM. The ticker symbol is used to trade CEL-SCI shares on the stock exchange.
CEL-SCI paid dividends every year for the past 0 years.
CEL-SCI is assigned to the 'Health' sector.
The dividends of CEL-SCI are distributed in USD.
CEL-SCI stock
CEL-SCI Ticker
All fundamentals and in-depth analysis of CEL-SCI
Our stock analysis for CEL-SCI stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CEL-SCI. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.